# T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/t-cell-metagene-predicts-a-favorable-prognosis-in-estrogen-receptor-negative-and/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Achim Rody,Uwe Holtrich,L. Pusztai,Cornelia Liedtke,R. Gaetje,Eugen Ruckhaeberle,Christine Solbach,Lars Hanker,A. Ahr,Dirk Metzler,Knut Engels,Thomas Karn,Manfred Kaufmann |
| Citations | 484 |
| DOI | 10.1186/bcr2234 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://breast-cancer-research.biomedcentral.com/counter/pdf/10.1186/bcr2234 |
| OpenAlex ID | https://openalex.org/W2053122486 |
| PMID | 19272155 |
| Type | article |
| Year | 2009 |

## Paper authors

- [Achim Rody](https://scholariq.org/researchers/achim-rody/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.